Last year in May, Danco Laboratories, which makes the abortion-inducing drug Mifeprex (mifepristone), filed paperwork with the FDA to update the guidelines for use of the drug. Give further research on how it works, they wanted to loosen the restrictions on who could use it and when.
The political implications were certainly not lacking — anti-abortion lawmakers throughout the country have passed laws to enforce strict adherence to the guidelines (which in this case were simply not accurate anymore) rather than deferring to medical experts. But to the surprise of many, the guidelines were indeed updated. Politics had nothing to do with it. Instead, the basis for the change was — wait for it — scientific progress.